7.7% Above Target

Wall Street's consensus price target for INCY is $108.92, -7.7% from its current price of $118.05. The below-market target from 44 analysts suggests limited near-term appreciation.

INCY has a consensus rating of "Buy" based on 44 Wall Street analysts. The rating breakdown is predominantly bullish, with 23 Buy/Strong Buy ratings. The consensus 12-month price target of $108.92 implies -7.7% downside from current levels.

With a forward P/E of 15.4407x, INCY trades at a relatively low valuation. The consensus target of $108.92 implies -7.7% move, suggesting the market may be pricing in risks.

The most bullish Wall Street analyst has a price target of $140 for INCY, while the most conservative target is $90. The consensus of $108.92 represents the median expectation. Our quantitative valuation model projects a bull case target of $183 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

INCY is heavily covered by Wall Street, with 44 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 23 have Buy ratings, 20 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month INCY stock forecast based on 44 Wall Street analysts shows a consensus price target of $108.92, with estimates ranging from $90 (bear case) to $140 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $139, with bear/bull scenarios of $87/$183.

Our quantitative valuation model calculates INCY's fair value at $139 (base case), with a bear case of $87 and bull case of $183. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

INCY trades at a forward P/E ratio of 15.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Analysts are cautious on INCY, with 1 Sell ratings and a price target of $108.92 (-7.7% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

INCY analyst price targets range from $90 to $140, a 46% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $108.92 consensus represents the middle ground. Our model's $87-$183 range provides an independent fundamental perspective.